Chloramphenicol Palmitate
Spezifikationen
530-43-8CAS-Nummer
208-477-9EG-Nummer
[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] hexadecanoateIUPAC-Name
C27H42Cl2N2O6Chemische Formel
561.5 g/molMolekulargewicht
CHLORAMPHENICOL PALMITATE; 530-43-8; Detreopal; CAP-palmitate; Chloromycetin palmitate; Chloramphenicol monopalmitate; Clorolifarina; DTXSID9048699; Chlorambon; 43VU4207NW; CHEBI:3605; DTXCID9028625; NSC-756675; (2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl hexadecanoate; Chlorolifarina; (2R,3R)-2-((dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propyl hexadecanoate; Chloramphenicoli palmitas; RefChem:54772; Chloromycetin Palmitate Oral Suspension; (2R,3R)-2-(Dichloroacetyl)amino-3-hydroxy-3-(4-nitrophenyl)propan-1-yl palmitate; 208-477-9; N3EHB2DP99; (2R,3R)-2-(2,2-Dichloroacetamido)-3-hydroxy-3-(4-nitrophenyl)propyl palmitate; MFCD00083597; C27H42Cl2N2O6; 125637-16-3; NCGC00159489-04; (2R,3R)-2-(2,2-dichloroacetamido)-3-hydroxy-3-(4-nitrophenyl)propyl hexadecanoate; [(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] hexadecanoate; Rel-(2R,3R)-2-(2,2-dichloroacetamido)-3-hydroxy-3-(4-nitrophenyl)propyl palmitate; Hexadecanoic acid, 2-((2,2-dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propyl ester, (R-(R*,R*))-; CAP-P; UNII-43VU4207NW; Chloramphenicol palmitate [JAN]; Chloramphenicol palmitate (ester); Chloramphenicol palmitate; (2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl hexadecanoate; EINECS 208-477-9; BRN 2826438; Chloramphenicol palmitate [USP:BAN:JAN]; chloramphenicol-palmitate; AI3-51715; CHEMBL1506; Chloromycetin palmitate (TN); 4-13-00-02753 (Beilstein Handbook Reference); SCHEMBL193727; orb1306627; 2-[(Dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl palmitate; HY-B1599R; GLXC-23172; HY-B1599; Chloramphenicol palmitate (Standard); Tox21_113094; EBC-27322; CHLORAMPHENICOL PALMITATE [MI]; AKOS025401796; AKOS040744613; Chloramphenicol palmitate (JP18/USP); DB14658; NSC 756675; CHLORAMPHENICOL PALMITATE [MART.]; CHLORAMPHENICOL PALMITATE [VANDF]; NCGC00348371-01; AC-25653; CAS-530-43-8; CHLORAMPHENICOL PALMITATE [WHO-DD]; CHLORAMPHENICOL PALMITATE [WHO-IP]; D-threo-(-)-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)acetamide alpha-palmitate; Hexadecanoic acid, 2-((dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propyl ester, (R-(R*,R*))-; Chloramphenicol palmitate (Polymorph A) RS; C3258; CS-0013525; NS00002811; CHLORAMPHENICOL PALMITATE [GREEN BOOK]; CHLORAMPHENICOL PALMITATE [EP MONOGRAPH]; CHLORAMPHENICOL PALMITATE [ORANGE BOOK]; CHLORAMPHENICOL PALMITATE [USP IMPURITY]; D01072; T20525; CHLORAMPHENICOL PALMITATE [USP MONOGRAPH]; CHLORAMPHENICOLI PALMITAS [WHO-IP LATIN]; EN300-19650994; Q27106147; Chloramphenicol palmitate, VETRANAL(TM), analytical standard; 2,2-Dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)-2-propyl]acetamide Palmitate; Chloramphenicol palmitate, United States Pharmacopeia (USP) Reference Standard; D-(-)-threo-2-Dichloroacetamido-1-(4-nitrophenyl)-1,3-propanediol Palmitate; 106322-62-7; D-THREO-(-)-2,2-DICHLORO-N-(.BETA.-HYDROXY-.ALPHA.-(HYDROXYMETHYL)-P-NITROPHENETHYL)ACETAMIDE .ALPHA.-PALMITATE; Hexadecanoic acid, (2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl ester; Hexadecanoic acid, 2-((2,2-dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl) propyl ester, (R-(R*,R*))-; Palmitic acid, alpha-ester with D-threo-(-)-2,2-dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)acetamideSynonyme
